These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8918852)

  • 1. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program.
    Goldberg L; Elliot D; Clarke GN; MacKinnon DP; Moe E; Zoref L; Green C; Wolf SL; Greffrath E; Miller DJ; Lapin A
    JAMA; 1996 Nov; 276(19):1555-62. PubMed ID: 8918852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adolescents Training and Learning to Avoid Steroids (ATLAS) prevention program. Background and results of a model intervention.
    Goldberg L; Elliot DL; Clarke GN; MacKinnon DP; Zoref L; Moe E; Green C; Wolf SL
    Arch Pediatr Adolesc Med; 1996 Jul; 150(7):713-21. PubMed ID: 8673196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing substance use and disordered eating: initial outcomes of the ATHENA (athletes targeting healthy exercise and nutrition alternatives) program.
    Elliot DL; Goldberg L; Moe EL; Defrancesco CA; Durham MB; Hix-Small H
    Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1043-9. PubMed ID: 15520341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors.
    Goldberg L; MacKinnon DP; Elliot DL; Moe EL; Clarke G; Cheong J
    Arch Pediatr Adolesc Med; 2000 Apr; 154(4):332-8. PubMed ID: 10768668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and outcome of a curriculum to prevent disordered eating and body-shaping drug use.
    Elliot DL; Moe EL; Goldberg L; DeFrancesco CA; Durham MB; Hix-Small H
    J Sch Health; 2006 Feb; 76(2):67-73. PubMed ID: 16466469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention and prevention of steroid use in adolescents.
    Elliot D; Goldberg L
    Am J Sports Med; 1996; 24(6 Suppl):S46-7. PubMed ID: 8947428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediating mechanisms in a program to reduce intentions to use anabolic steroids and improve exercise self-efficacy and dietary behavior.
    MacKinnon DP; Goldberg L; Clarke GN; Elliot DL; Cheong J; Lapin A; Moe EL; Krull JL
    Prev Sci; 2001 Mar; 2(1):15-28. PubMed ID: 11519372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic-androgenic steroid use among high school football players.
    Stilger VG; Yesalis CE
    J Community Health; 1999 Apr; 24(2):131-45. PubMed ID: 10202692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of baseline by treatment interactions in a drug prevention and health promotion program for high school male athletes.
    Fritz MS; MacKinnon DP; Williams J; Goldberg L; Moe EL; Elliot DL
    Addict Behav; 2005 Jun; 30(5):1001-5. PubMed ID: 15893095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of androgenic-anabolic steroid use in adolescents in two regions of South Africa.
    Lambert MI; Titlestad SD; Schwellnus MP
    S Afr Med J; 1998 Jul; 88(7):876-80. PubMed ID: 9698716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an anabolic steroid education program on knowledge and attitudes of high school football players.
    Goldberg L; Bosworth EE; Bents RT; Trevisan L
    J Adolesc Health Care; 1990 May; 11(3):210-4. PubMed ID: 2358388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining athletes' attitudes toward using anabolic steroids and their knowledge of the possible effects.
    Anshel MH; Russell KG
    J Drug Educ; 1997; 27(2):121-45. PubMed ID: 9270210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks.
    Tanner SM; Miller DW; Alongi C
    Clin J Sport Med; 1995; 5(2):108-15. PubMed ID: 7882111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic steroid education and adolescents: do scare tactics work?
    Goldberg L; Bents R; Bosworth E; Trevisan L; Elliot DL
    Pediatrics; 1991 Mar; 87(3):283-6. PubMed ID: 2000267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position stand on androgen and human growth hormone use.
    Hoffman JR; Kraemer WJ; Bhasin S; Storer T; Ratamess NA; Haff GG; Willoughby DS; Rogol AD
    J Strength Cond Res; 2009 Aug; 23(5 Suppl):S1-S59. PubMed ID: 19620932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway.
    Jenssen IH; Johannessen KB
    Body Image; 2015 Jan; 12():6-13. PubMed ID: 25261635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mediation analysis of the ATHENA intervention for female athletes: prevention of athletic-enhancing substance use and unhealthy weight loss behaviors.
    Ranby KW; Aiken LS; Mackinnon DP; Elliot DL; Moe EL; McGinnis W; Goldberg L
    J Pediatr Psychol; 2009; 34(10):1069-83. PubMed ID: 19386771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with anabolic-androgenic steroid use among adolescents.
    Bahrke MS; Yesalis CE; Kopstein AN; Stephens JA
    Sports Med; 2000 Jun; 29(6):397-405. PubMed ID: 10870866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year follow-up of a coach-delivered dating violence prevention program: a cluster randomized controlled trial.
    Miller E; Tancredi DJ; McCauley HL; Decker MR; Virata MCD; Anderson HA; O'Connor B; Silverman JG
    Am J Prev Med; 2013 Jul; 45(1):108-112. PubMed ID: 23790995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dietary supplements and anabolic-androgenic steroids among Finnish adolescents in 1991-2005.
    Mattila VM; Parkkari J; Laakso L; Pihlajamäki H; Rimpelä A
    Eur J Public Health; 2010 Jun; 20(3):306-11. PubMed ID: 19710236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.